Athanasios Konstantinidis1, Edmund Cheesman2, James O'Sullivan3, Juljia Pavaine4, Shivaram Avula5, Barry Pizer6, John-Paul Kilday7. 1. Department of Haematology/Oncology, Royal Manchester Children's Hospital, Manchester, UK. 2. Children's Brain Tumour Research Network, Royal Manchester Children's Hospital, Manchester, UK; Department of Histopathology, Royal Manchester Children's Hospital, Manchester, UK; The Centre for Paediatric, Teenage and Young Adult Cancer, Division of Cancer Sciences, The University of Manchester, Manchester, UK. 3. Division of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK; Manchester Centre for Genomic Medicine, St. Mary's Hospital, Manchester University Foundation NHS Trust, Health Innovation Manchester, Manchester, UK. 4. Academic Unit of Paediatric Radiology, Royal Manchester Children's Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Sciences Centre, Manchester, UK; Division of Informatics, Imaging and Data Sciences, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK. 5. Department of Neuroradiology, Alder Hey Children's Hospital, Liverpool, UK. 6. Department of Haematology/Oncology, Alder Hey Children's Hospital, Liverpool, UK. 7. Department of Haematology/Oncology, Royal Manchester Children's Hospital, Manchester, UK; Children's Brain Tumour Research Network, Royal Manchester Children's Hospital, Manchester, UK. Electronic address: John-Paul.Kilday@mft.nhs.uk.
Abstract
BACKGROUND: Intracranial angiomatoid fibrous histiocytomas (AFHs) are very rare tumors. Histologically, classical cases have been reported exclusively in adults, with myxoid variants identified only in children. Here, we report the clinical presentation, treatment, biopsy, and molecular test results for 2 children with classical intracranial AFH and combine this with a literature review of published intracranial AFH and AFH-like cases. CASE DESCRIPTION: Two young girls presenting with abnormal neurologic signs, received diagnoses of intracranial AFHs from histopathologic analysis. No myxoid features were identified. Fluorescence in situ hybridization and reverse transcriptase polymerase chain reaction testing demonstrated EWS1-ATF1 and EWS1-CREM gene fusions, respectively, verified by Sanger sequencing. Both patients underwent surgery only. The first child experienced local recurrence 5 years from initial surgery. Following a further complete resection, this patient has remained recurrence free over a subsequent 6-year follow-up period. The second patient has recently experienced local multinodular recurrence 28 months after initial surgery and is awaiting surgical re-excision. No additional chemotherapy/radiotherapy has been administered to either patient. CONCLUSIONS: This report describes the first 2 cases of nonmyxoid intracranial AFH in children; confirmed by molecular analysis. Our results suggest that a tumor spectrum incorporating classical and myxoid intracranial AFHs can occur in children and that gross total resection represents the treatment strategy of choice at diagnosis or following recurrence. Crown
BACKGROUND:Intracranial angiomatoid fibrous histiocytomas (AFHs) are very rare tumors. Histologically, classical cases have been reported exclusively in adults, with myxoid variants identified only in children. Here, we report the clinical presentation, treatment, biopsy, and molecular test results for 2 children with classical intracranial AFH and combine this with a literature review of published intracranial AFH and AFH-like cases. CASE DESCRIPTION: Two young girls presenting with abnormal neurologic signs, received diagnoses of intracranial AFHs from histopathologic analysis. No myxoid features were identified. Fluorescence in situ hybridization and reverse transcriptase polymerase chain reaction testing demonstrated EWS1-ATF1 and EWS1-CREM gene fusions, respectively, verified by Sanger sequencing. Both patients underwent surgery only. The first child experienced local recurrence 5 years from initial surgery. Following a further complete resection, this patient has remained recurrence free over a subsequent 6-year follow-up period. The second patient has recently experienced local multinodular recurrence 28 months after initial surgery and is awaiting surgical re-excision. No additional chemotherapy/radiotherapy has been administered to either patient. CONCLUSIONS: This report describes the first 2 cases of nonmyxoid intracranial AFH in children; confirmed by molecular analysis. Our results suggest that a tumor spectrum incorporating classical and myxoid intracranial AFHs can occur in children and that gross total resection represents the treatment strategy of choice at diagnosis or following recurrence. Crown
Authors: M Adelita Vizcaino; Caterina Giannini; Howard T Chang; Benjamin R Kipp; Karen Fritchie; Rachael Vaubel Journal: Brain Tumor Pathol Date: 2021-01-12 Impact factor: 3.298
Authors: André Steven; Michael Friedrich; Paul Jank; Nadine Heimer; Jan Budczies; Carsten Denkert; Barbara Seliger Journal: Cell Mol Life Sci Date: 2020-04-28 Impact factor: 9.261
Authors: Emily A Sloan; Jason Chiang; Javier E Villanueva-Meyer; Sanda Alexandrescu; Jennifer M Eschbacher; Wesley Wang; Manuela Mafra; Nasir Ud Din; Emily Carr-Boyd; Michael Watson; Michael Punsoni; Angelica Oviedo; Ahmed Gilani; Bette K Kleinschmidt-DeMasters; Dylan J Coss; M Beatriz Lopes; Corey Raffel; Mitchel S Berger; Susan M Chang; Alyssa Reddy; Biswarathan Ramani; Sean P Ferris; Julieann C Lee; Jeffrey W Hofmann; Soo-Jin Cho; Andrew E Horvai; Melike Pekmezci; Tarik Tihan; Andrew W Bollen; Fausto J Rodriguez; David W Ellison; Arie Perry; David A Solomon Journal: Brain Pathol Date: 2021-01-28 Impact factor: 6.508
Authors: Oscar Lopez-Nunez; Barbara Cafferata; Mariarita Santi; Sarangarajan Ranganathan; Thomas M Pearce; Scott M Kulich; Kelly M Bailey; Alberto Broniscer; Sabrina Rossi; Angelica Zin; MacLean P Nasrallah; Marilyn M Li; Yiming Zhong; Evelina Miele; Rita Alaggio; Lea F Surrey Journal: Brain Pathol Date: 2020-11-06 Impact factor: 6.508